Spire Healthcare Group plc (LON:SPI)

London flag London · Delayed Price · Currency is GBP · Price in GBX
160.60
-3.40 (-2.07%)
Apr 28, 2026, 5:07 PM GMT
Market Cap643.36M -12.8%
Revenue (ttm)1.58B +4.5%
Net Income16.40M -35.4%
EPS0.04 -35.5%
Shares Out400.60M
PE Ratio40.15
Forward PE20.06
Dividend0.02 (0.91%)
Ex-Dividend DateMay 21, 2026
Volume1,218,171
Average Volume1,319,294
Open163.00
Previous Close164.00
Day's Range159.40 - 165.00
52-Week Range140.80 - 256.50
Beta0.91
RSI47.18
Earnings DateJul 30, 2026

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It operates in two segments: Hospitals Business and Primary Care. The company provides diagnostics, inpatient, day case, and outpatient care in areas, including orthopedics, gynaecology, cardiology, neurology, oncology, and general surgery; and primary care needs of outpatients, such as GP services, occupational health services, and mental and physical health services. It also offers various treatments in the areas ... [Read more]

Sector Healthcare
Founded 2007
Employees 17,800
Stock Exchange London Stock Exchange
Ticker Symbol SPI
Full Company Profile

Financial Performance

In 2025, Spire Healthcare Group's revenue was 1.58 billion, an increase of 4.54% compared to the previous year's 1.51 billion. Earnings were 16.40 million, a decrease of -35.43%.

Financial Statements

News

Spire Healthcare Share Price Is Down 38% From Its Peak — But the Business Keeps Growing

You can get a visceral sense of what the company does and why it matters to the people who use it by walking through the reception of any Spire Healthcare hospital, such as the Spire Manchester Hospit...

13 days ago - ABC Money

Spire Healthcare Group PLC (LSE:SPI) Full Year 2025 Earnings Call Highlights: Navigating Growth ...

Spire Healthcare Group PLC (LSE:SPI) Full Year 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges

7 weeks ago - GuruFocus

Full Year 2025 Spire Healthcare Group PLC Earnings Call Transcript

Full Year 2025 Spire Healthcare Group PLC Earnings Call Transcript

7 weeks ago - GuruFocus

Spire Healthcare Group Earnings Call Transcript: H2 2025

Revenue grew 4.5% with strong private and primary care momentum, while NHS volumes slowed due to budget constraints. Adjusted EBITDA rose 3.2% and free cash flow surged 65%, supported by £30m in transformation savings. NHS uncertainty remains a key risk for 2026.

7 weeks ago - Transcripts

UK’s biggest private hospital provider Spire in talks on sale to private equity

Shares in FTSE 250 company jump as it reveals Bridgepoint and Triton are among groups interested in takeover Business live – latest updates The UK’s biggest private hospital provider, Spire Healthcare...

3 months ago - The Guardian

UK Stock Market News: Big Yellow, Spire Healthcare, Mony Group

Business rate impact update from Big Yellow, Spire Healthcare guides FY forecasts lower, Mony Group sees FY25 on track, headwinds abating

5 months ago - The Armchair Trader

Half Year 2025 Spire Healthcare Group PLC Earnings Call Transcript

Half Year 2025 Spire Healthcare Group PLC Earnings Call Transcript

6 months ago - GuruFocus

Spire Healthcare soars as it goes up for sale

The update pushed shares up more than 18 per cent in early trading before it closed 14.1 per cent, or 31p, up at 247p.

7 months ago - This is Money

Hospital operator Spire considering potential sale

Shares in FTSE 250 firm Spire Healthcare shot higher on Friday morning after it confirmed it would consider options including a sale.

7 months ago - Evening Standard

European Stocks Rise; SPIRE HEALTHCARE (SPI) Gains on Sale Speculation

European Stocks Rise; SPIRE HEALTHCARE (SPI) Gains on Sale Speculation

7 months ago - GuruFocus

Private hospitals group Spire faces investor calls to explore sale

Spire Healthcare, the private hospitals operator, is facing calls from leading investors to put itself up for sale.

7 months ago - Sky News

Spire Healthcare Group Earnings Call Transcript: H1 2025

H1 results met guidance with 4.9% revenue growth and 2.8% higher adjusted EBITDA, driven by efficiency savings and strategic transformation. NHS and primary care segments showed strong growth, while private volumes faced headwinds. Full-year outlook remains in line with expectations.

9 months ago - Transcripts

Spire Healthcare Group Transcript: Status Update

Primary care is a major growth focus, targeting £40 million EBITDA through organic expansion, new services, and M&A, with strong NHS contract visibility and a CapEx-light model. Service integration, digital delivery, and a data-driven approach underpin operational efficiency and market reach.

1 year ago - Transcripts

Spire Healthcare Group Earnings Call Transcript: H2 2024

Full-year 2024 results showed strong revenue and margin growth, with adjusted EBITDA up 9% and all core metrics meeting guidance. Efficiency programs are ahead of plan, offsetting significant cost pressures, and the outlook remains positive for mid-single-digit growth in 2025.

1 year ago - Transcripts

Meet the private healthcare boss who’s ‘proud the NHS exists’

Justin Ash’s Spire Healthcare makes millions from hip ops and therapy and wants to expand further – but only in a ‘complementary’ way to the state provider In a 1980s redbrick building near Gatwick ai...

1 year ago - The Guardian

Spire Healthcare: invest in the booming demand for private healthcare

Spire Healthcare is one of the few listed companies benefiting from the growing trend in private healthcare. Should you invest?

1 year ago - MoneyWeek

Spire Healthcare reports profit and revenue jump as its work for NHS increases

Private hospital group also benefited from higher take-up of private health insurance among working-age people Spire Healthcare, one of the UK’s biggest private hospital groups, has reported a jump in...

1 year ago - The Guardian

Spire Healthcare Group Earnings Call Transcript: H1 2024

Strong H1 2024 results with revenue up 12.7% and adjusted EBITDA up 10.8%, driven by PMI and NHS growth, margin expansion, and successful integration of Vita. Cost savings and efficiency programs are on track, supporting unchanged full-year guidance and positive medium-term outlook.

1 year ago - Transcripts